Jump to content

Acura Pharmaceuticals

From Wikipedia, the free encyclopedia
Acura Pharmaceuticals Inc.
Company typePublic
NasdaqACUR
IndustryPharmaceutical industry
Founded1935; 89 years ago (1935)[1]: 3 
HeadquartersPalatine, Illinois
ProductsPharmaceuticals
RevenueIncrease US$ .75 million (2015)[2]
Websiteacurapharm.com

Acura Pharmaceuticals Inc. is a pharmaceutical company focused on the development and commercialization of deterrents to medication abuse and misuse.[3] As of 2012, the company had several opioid products under development, which would use "Aversion Technology".[4] As of 2014, it was a publicly traded company, listed on NASDAQ under the symbol "ACUR".

History

[edit]

In 2013, the Company settled Oxecta patent litigation with Impax Laboratories (IPXL) and Par Pharmaceutical.[5]

License agreements

The company has an agreement to license, develop and commercialize opioid analgesic products with King Pharmaceuticals.[6]

Product adoptions

In 2013, multiple retailers – including Kroger and Fruth Pharmacy – stocked Acura's product Nexafed.[7][8]

References

[edit]
  1. ^ "ACURA PHARMACEUTICALS, INC" (PDF). EDGAR Online. Form 10-K, 1996. Acura Pharmaceuticals. March 31, 1997. Retrieved February 15, 2014.[permanent dead link]
  2. ^ "Acura Pharmaceuticals Financial Statements". United States Securities and Exchange Commission.
  3. ^ "Acura Pharmaceuticals Announces Second Quarter 2020 Financial Results". AP NEWS. 2020-08-14. Retrieved 2021-07-22.
  4. ^ "Acura Pharmaceuticals, Inc". Google Finance. 266634. Archived from the original on 10 May 2014. Retrieved February 15, 2014.{{cite web}}: CS1 maint: bot: original URL status unknown (link)
  5. ^ "Acura Pharmaceuticals Inc Announces Settlement of Oxecta Patent Litigation With Par Pharmaceutical and Impax Laboratories Inc". Reuters. Reuters. October 9, 2013. Archived from the original on February 15, 2014.
  6. ^ "ACURA PHARMACEUTICALS INC (ACUR) Company Profile & Facts - Yahoo Finance".
  7. ^ Olsavsky, Rebecca (February 4, 2014). "Kroger stocks meth-resistant drug". Herald-Star. Archived from the original on February 15, 2014. Retrieved February 15, 2014.
  8. ^ "New Pseudoephedrine Drug Could Hop Back Over the Counter". PharmExec. 11 December 2012. Retrieved 2021-07-22.
[edit]